4.8 Article

Super Natural II-a database of natural products

期刊

NUCLEIC ACIDS RESEARCH
卷 43, 期 D1, 页码 D935-D939

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gku886

关键词

-

资金

  1. Deutsche Forschunsgemeinschaft [DFG] [GRK 1172, GRK 1360]
  2. European Union Seventh Framework Programme SYNSYS [HEALTH-2009-2.1.2-1, 242167]
  3. Berlin-Brandenburg Research Platform BB3R (BMBF) [031A262C]
  4. Innovative Toxicology for the Reduction of Animal Experimentation (e:ToP), Immunotox Project (BMBF) [031A268B]
  5. Biotechnology and Biological Sciences Research Council [BB/J004529/1]
  6. BBSRC [BBS/E/F/00044461] Funding Source: UKRI
  7. Biotechnology and Biological Sciences Research Council [BBS/E/F/00044461] Funding Source: researchfish

向作者/读者索取更多资源

Natural products play a significant role in drug discovery and development. Many topological pharmacophore patterns are common between natural products and commercial drugs. A better understanding of the specific physicochemical and structural features of natural products is important for corresponding drug development. Several encyclopedias of natural compounds have been composed, but the information remains scattered or not freely available. The first version of the Supernatural database containing similar to 50 000 compounds was published in 2006 to face these challenges. Here we present a new, updated and expanded version of natural product database, Super Natural II (http://bioinformatics.charite.de/supernatural), comprising similar to 326 000 molecules. It provides all corresponding 2D structures, the most important structural and physicochemical properties, the predicted toxicity class for similar to 170 000 compounds and the vendor information for the vast majority of compounds. The new version allows a template-based search for similar compounds as well as a search for compound names, vendors, specific physical properties or any substructures. Super Natural II also provides information about the pathways associated with synthesis and degradation of the natural products, as well as their mechanism of action with respect to structurally similar drugs and their target proteins.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据